BioSpace News Archive

Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory for clinical trials, based in Australia, has developed the world’s most accurate cannabinoid assay.

Theralink Technologies (OTC: OBMP) (“Theralink” or the “Company”), formerly OncBioMune Pharmaceuticals, Inc. , a molecular profiling company specializing in patented, biomarker assay services that target multiple areas of oncology, today announced the completion of its previously announced corporate name change to Theralink Technolog

MP0317 activates multiple antitumor immune cell types in vitro when in the presence of tumor stroma associated FAP MP0317 mouse surro gate localizes to FAP-expressing tumors and induces strong and durable anti-tumor responses without systemic toxicity, and demonstrates strong anti-tumor immune memory responses ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / September 24, 2020 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-bu

Relationship to enhance patient outcomes, efficiency for healthcare provider servicing the Central Coast of California

Signify Health, a leading provider of technology-enabled healthcare solutions designed to keep people healthy and happy at home, and Ciox Health, a leader in health information management, today announced a strategic alliance to develop a master patient record for payers and risk-bearing health systems participating in value-based care models.

Rhizen Pharmaceuticals S.A. today announced the publication of the results from the Phase I/Ib study of Tenalisib (RP6530), the company’s novel next generation dual PI3K δ/γ inhibitor, in the journal Cancers . --- Single-agent Tenalisib was well tolerated with a good overall response rate (ORR) in both peripheral and cutaneous T-cell Lymphoma patients (PTCL and CTCL) The results include safety and efficacy informatio

This year, a flu shot is more important than ever. That’s why California hospitals, physicians and public health officials are joining with a coalition of health care stakeholders, social service organizations and governmental agencies to launch the statewide “FightFluTogether” campaign.

“The U.S. Food and Drug Administration has been working with the Centers for Disease Control and Prevention, state, local and international partners on an investigation of an outbreak of Salmonella Stanley infections likely linked to wood ear mushrooms imported by Wismettac Asian Foods, Inc., of Santa Fe Springs, California.

PMV Pharmaceuticals, Inc., a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations, today announced the pricing of its initial public offering of 11,765,000 shares of common stock at a public offering price of $18.00 per share

Greenwich LifeSciences, Inc. (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced the pricing of its initial public offering of 1,260,870 shares of its common stock at a public offering price of $5.75 per share for gross proceeds of $7,250,002,